Insulin Resistance in Nonalcoholic Fatty Liver Disease: A Case Control Study
Public ClinicalTrials.gov record NCT00637520. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
We hypothesize that insulin resistance is characteristic of nonalcoholic fatty liver disease as compared to age, gender, non-diabetic BMI-matched control subjects, both healthy and those with non-cirrhotic, non-steatotic liver disease.
Study identification
- NCT ID
- NCT00637520
- Recruitment status
- Terminated
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 29 participants
Conditions and interventions
Interventions
Not listed
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 30, 2007
- Primary completion
- Mar 28, 2013
- Completion
- Apr 12, 2017
- Last update posted
- Jul 10, 2017
2007 – 2017
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Duke University Medical Center | Durham | North Carolina | 27710 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Recently updated Insulin Resistance trials
Other public records listing Insulin Resistance. Sorted by last update posted; newest first. Not a recommendation.
- NCT07778524: Alpelisib Challenge Test (ACT) Not yet recruiting
- NCT07653464: Interplay of Central and Peripheral Vascular Effects of Insulin in Obesity Not yet recruiting
- NCT07724522: Prebiotic Inulin for Late-Reproductive Individuals Recruiting
- NCT05933707: Small Extracellular Vesicles and Insulin Action Recruiting
- NCT06007404: Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents Recruiting
- NCT07403604: Effect of Insulin Lowering on Lipogenesis Recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00637520, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 10, 2017 · Synced Sep 4, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00637520 live on ClinicalTrials.gov.